Edesa Biotech shareholders approve 67,000-share increase to equity plan, re-elect all directors

Edesa Biotech, Inc.

All seven director nominees elected with ~818-819 thousand votes for each; 654k broker non-votes.
Advisory vote on executive compensation approved: 677,967 for, 122,761 against, 62,400 abstain.
Plan amendment increasing shares by 67,000 approved: 660,015 for, 151,395 against, 51,718 abstain.
Approximately 47% of outstanding shares (1,517,529) represented at the meeting.
MNP LLP appointed as auditors for FY ending Sept 30, 2024 with 1,463,707 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.